Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BBNX
GYRE
Add up to 3 more stocks
BBNX
Beta Bionics, Inc.
-2.86%
$18.41-0.54Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$828.21M
52W Range
$8.80 - $32.71
GYRE
Gyre Therapeutics, Inc.
-3.88%
$7.07-0.28Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$787.67M
52W Range
$5.44 - $9.42
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.23 | 7.30 |
| P/S Ratio | 6.96 | 6.60 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 58.3% | 94.3% |
| Operating Margin | -69.8% | 9.9% |
| Net Margin | -61.3% | -14.5% |
| ROE | -28.5% | -13.3% |
| ROA | -25.0% | -8.7% |
| ROIC | -31.2% | -9.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 8.88 | 4.26 |
| Quick Ratio | 7.96 | 3.86 |
| Debt/Equity | 0.03 | 0.03 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.